Ken Griffin Ginkgo Bioworks Holdings, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $1,272 - $2,004	-1,200 Reduced 0.21%	558,000 $647,000
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $36,792 - $52,268	29,200 Added 5.51%	559,200 $945,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $285,775 - $450,850	177,500 Added 50.35%	530,000 $959,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $114,797 - $196,365	100,700 Added 39.99%	352,500 $655,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $67,885 - $123,890	-56,571 Reduced 18.35%	251,800 $334,000

Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $22,052 - $47,622	-13,529 Reduced 4.2%	308,371 $521,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $32,558 - $166,804	-44,600 Reduced 12.17%	321,900 $1 Million

359

1.26B

845K

2.54M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $438M
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.